Gul Obert

Managed Home Dialysis product portfolio in nephorology market. Responsible for pre-launch and launch activities, such as brand plan development, budget forecasting, supply chain planning.

reported to the CEO and member of Chief Executive Committee, established and led a marketing and business development unit with 10 Marketing and Medical Manager based on four pillars: MM of a diverse medical device product portfolio including new product launches, Drove internal operational excellence, CRM, Developed new business opportunities including business partner management and product development.

Led a marketing and sales team with one Product Manager and six Medical Representatives. Developed launch strategy and managed all pre-launch activities of blockbuster drug Xarelto® (Anticoagulant Market), including market, product and company shaping issues.

Managed Spiriva Alliance of Boehringer Ingelheim and Pfizer within Respiratory Medico- Marketing Team including management committee lead, performance review, contract management, reporting to Global VP Respiratory. Coordinated worldwide alliance manager team.

Led marketing and sales hospital team with 12 Medical Representatives and a Junior Product Manager. In charge of marketing and sales activities of hospital product portfolio, like Actilyse® and Metalyse®.

Managed mature product portfolio in rheumatology, cardiology and neurology market. Responsible for blockbuster product Pradaxa® pre-launch activities, such as brand plan development, budget forecasting, supply chain planning.